Pomalidomide Withdrawn Phase 2 Trials for Pulmonary Fibrosis Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01135199Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis